Lymphoblastic leukemia can be cured in some patients after active treatment. Whether or not it can be cured is often related to the type of lymphoblastic leukemia, the age of the patient, the development of the disease and other factors.
1. Acute lymphoblastic leukemia patients with early staging, the younger the patient is, the better the treatment effect is, and a small number of patients can be cured.
2. Some patients with chronic lymphocytic leukemia do not need to be treated, and only need regular follow-up. When they meet the treatment indications, they can receive standardized treatment to prolong their survival. However, most chronic lymphocytic leukemias cannot be cured and require long-term treatment to control the progression of the disease.
Acute lymphoblastic leukemia is commonly treated with chemotherapy, which is often combined with vincristine, doxorubicin, prednisone, etc. After chemotherapy, depending on the patient’s response to the chemotherapy drugs, the patient can choose whether to supplement with radiotherapy or targeted therapy (cedarbenamide).
Commonly used therapeutic drugs for chronic lymphocytic leukemia include nitrogen mustard phenylbutyrate and ibrutinib.
Patients with lymphocytic leukemia should actively seek medical treatment for standardized treatment, and strictly follow the doctor’s instructions for medication, so as to prolong life and improve the quality of life as much as possible.